Homocysteine, the kidney, and vascular disease.

Homocysteine, the kidney, and vascular disease.

Manylion Llyfryddiaeth
Prif Awduron:	Haynes, R, Clarke, R
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2012

Eitemau Tebyg

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
gan: Haynes, R, et al.
Cyhoeddwyd: (2012)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
gan: Clarke, R, et al.
Cyhoeddwyd: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
gan: Clarke, R, et al.
Cyhoeddwyd: (2011)

Plasma Homocysteine and Vascular Disease
gan: Kelly M Elian
Cyhoeddwyd: (2020-12-01)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
gan: Clarke, R, et al.
Cyhoeddwyd: (2007)

Homocysteine and cardiovascular disease. Overview.
gan: Clarke, R
Cyhoeddwyd: (1998)

Homocysteine and coronary heart disease.
gan: Clarke, R, et al.
Cyhoeddwyd: (2002)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
gan: Clarke, R
Cyhoeddwyd: (2011)

Homocysteine and prediction of coronary heart disease and stroke
gan: Clarke, R, et al.
Cyhoeddwyd: (2003)

Homocysteine-lowering trials for prevention of heart disease and stroke.
gan: Clarke, R
Cyhoeddwyd: (2005)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
gan: Clarke, R
Cyhoeddwyd: (2009)

Homocysteine, renal function, and risk of cardiovascular disease.
gan: Clarke, R, et al.
Cyhoeddwyd: (2003)

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
gan: Clarke, R
Cyhoeddwyd: (2002)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
gan: Clarke, R, et al.
Cyhoeddwyd: (2005)

Homocysteine and risk of cardiovascular disease and venous thrombosis
gan: Clarke, R, et al.
Cyhoeddwyd: (2003)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
gan: Clarke, R, et al.
Cyhoeddwyd: (1998)

Homocysteine, B vitamins, and the risk of dementia.
gan: Clarke, R
Cyhoeddwyd: (2007)

The Analysis of Asymetric Dimethylarginine and Homocysteine in Patients with Chronic Kidney Disease
gan: Tetty Hendrawati, et al.
Cyhoeddwyd: (2009-08-01)

Homocysteine exchange across skeletal muscle in patients with chronic kidney disease
gan: Giacomo Garibotto, et al.
Cyhoeddwyd: (2023-03-01)

Relation of kidney function and homocysteine in patients with hypothyroidism
gan: Qingrong Pan, et al.
Cyhoeddwyd: (2021-05-01)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
gan: Holman, R, et al.
Cyhoeddwyd: (2001)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
gan: Clarke, R, et al.
Cyhoeddwyd: (2007)

Association of homocysteine with traditional and non-traditional risk factors in patients with atherosclerotic vascular disease
gan: Emina Kiseljaković, et al.
Cyhoeddwyd: (2011-02-01)

Homocysteine And Neurological Disease
gan: Nagaraja D
Cyhoeddwyd: (2004-01-01)

Homocysteine and cardiovascular disease
gan: p yavari
Cyhoeddwyd: (2000-06-01)

Homocysteine and cardiovascular disease
Cyhoeddwyd: (2000-05-01)

Serum Homocysteine and Folic Acid Levels as Risk Factors of Chronic Kidney Disease
gan: Esa Loyallita LESTARI, et al.
Cyhoeddwyd: (2024-03-01)

HOMOCYSTEINE AND KIDNEY'S FUNCTIONAL STATUS OF THE CHILDREN WITH THE NEPHROTIC SYNDROME
gan: L.T. Faizova, et al.
Cyhoeddwyd: (2008-09-01)

HOMOCYSTEINE AND KIDNEY'S FUNCTIONAL STATUS OF THE CHILDREN WITH THE NEPHROTIC SYNDROME
gan: L.T. Faizova, et al.
Cyhoeddwyd: (2008-09-01)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
gan: Clarke, R, et al.
Cyhoeddwyd: (2001)

Comparison of plasma homocysteine and serum C-reactive protein in patients with Alzheimer's disease and vascular dementia
gan: Xu LIU, et al.
Cyhoeddwyd: (2015-08-01)

Prevalence of elevated levels of homocysteine (hyperhomocysteinemia) in patients with chronic kidney disease undergoing hemodialysis
gan: Rizaldy Taslim Pinzon, et al.
Cyhoeddwyd: (2019-09-01)

The concentration of homocysteine in patients after ischemic brain stroke and vascular dementia
gan: Nafija Serdarević, et al.
Cyhoeddwyd: (2011-04-01)

Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia
gan: Rita Moretti, et al.
Cyhoeddwyd: (2017-05-01)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
gan: Clarke, R, et al.
Cyhoeddwyd: (2001)

The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism.
gan: Limin Zhang, et al.
Cyhoeddwyd: (2011-01-01)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
gan: Clarke, R, et al.
Cyhoeddwyd: (1998)

Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials.
gan: Clarke, R
Cyhoeddwyd: (2000)

Vascular Homocysteine vs 5-Methyl-Tetrahydrofolate as Regulators of Vascular Redox and Endothelial Function in Human Vessels
gan: Antoniades, C, et al.
Cyhoeddwyd: (2008)

Vascular Homocysteine Versus 5-Methyl-Tetrahydrofolate As Regulators of Vascular Redox and Endothelial Function in Human Vessels
gan: Antoniades, C, et al.
Cyhoeddwyd: (2009)